# LiveRamp Holdings, Inc.: financial statements, quarterly

RAMP · NYSE · CIK 733269 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/ramp.md) · [Financials](/companies/ramp/financials.md) · [Filings](/companies/ramp/filings.md) · [Insiders](/companies/ramp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ramp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [160](/filings/0000733269-24-000039.md) | [174](/filings/0000733269-25-000015.md) | [172 d](/filings/0000733269-26-000025.md) | [176](/filings/0000733269-25-000042.md) | [185](/filings/0000733269-25-000057.md) | [195](/filings/0000733269-26-000012.md) | [189 d](/filings/0000733269-26-000025.md) | [195](/filings/0000733269-26-000047.md) | [200](/filings/0000733269-25-000057.md) | [212](/filings/0000733269-26-000012.md) | [206 d](/filings/0000733269-26-000025.md) | [214](/filings/0000733269-26-000047.md) |
| Cost of revenue | $m | [41.2](/filings/0000733269-24-000039.md) | [44.9](/filings/0000733269-25-000015.md) | [47.7 d](/filings/0000733269-26-000025.md) | [51.7](/filings/0000733269-25-000042.md) | [51.2](/filings/0000733269-25-000057.md) | [55.0](/filings/0000733269-26-000012.md) | [57.9 d](/filings/0000733269-26-000025.md) | [58.3](/filings/0000733269-26-000047.md) | [59.6](/filings/0000733269-25-000057.md) | [59.7](/filings/0000733269-26-000012.md) | [60.5 d](/filings/0000733269-26-000025.md) | [63.0](/filings/0000733269-26-000047.md) |
| Gross profit | $m | [119](/filings/0000733269-24-000039.md) | [129](/filings/0000733269-25-000015.md) | [124 d](/filings/0000733269-26-000025.md) | [124](/filings/0000733269-25-000042.md) | [134](/filings/0000733269-25-000057.md) | [140](/filings/0000733269-26-000012.md) | [131 d](/filings/0000733269-26-000025.md) | [137](/filings/0000733269-26-000047.md) | [140](/filings/0000733269-25-000057.md) | [153](/filings/0000733269-26-000012.md) | [146 d](/filings/0000733269-26-000025.md) | [151](/filings/0000733269-26-000047.md) |
| Research and development | $m | [33.7](/filings/0000733269-24-000039.md) | [37.8](/filings/0000733269-25-000015.md) | [45.2 d](/filings/0000733269-26-000025.md) | [44.1](/filings/0000733269-25-000042.md) | [43.9](/filings/0000733269-25-000057.md) | [42.7](/filings/0000733269-26-000012.md) | [45.9 d](/filings/0000733269-26-000025.md) | [39.6](/filings/0000733269-26-000047.md) | [37.0](/filings/0000733269-25-000057.md) | [33.8](/filings/0000733269-26-000012.md) | [37.8 d](/filings/0000733269-26-000025.md) | [37.1](/filings/0000733269-26-000047.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [8.2](/filings/0000733269-24-000039.md) | [15.2](/filings/0000733269-25-000015.md) | [(14.3) d](/filings/0000733269-26-000025.md) | [(5.2)](/filings/0000733269-25-000042.md) | [7.5](/filings/0000733269-25-000057.md) | [14.7](/filings/0000733269-26-000012.md) | [(11.5) d](/filings/0000733269-26-000025.md) | [7.2](/filings/0000733269-26-000047.md) | [21.4](/filings/0000733269-25-000057.md) | [39.5](/filings/0000733269-26-000012.md) | [15.3 d](/filings/0000733269-26-000025.md) | [20.2](/filings/0000733269-26-000047.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [10.2](/filings/0000733269-24-000039.md) | [8.4](/filings/0000733269-25-000015.md) | [(3.0) d](/filings/0000733269-26-000025.md) | [6.7](/filings/0000733269-25-000042.md) | [10.0](/filings/0000733269-25-000057.md) | [9.2](/filings/0000733269-26-000012.md) | [(0.5) d](/filings/0000733269-26-000025.md) | [3.2](/filings/0000733269-26-000047.md) | [(2.4)](/filings/0000733269-25-000057.md) | [3.0](/filings/0000733269-26-000012.md) | [(50.5) d](/filings/0000733269-26-000025.md) | [5.7](/filings/0000733269-26-000047.md) |
| Net income | $m | [4.9](/filings/0000733269-24-000039.md) | [14.0](/filings/0000733269-25-000015.md) | [(5.4) d](/filings/0000733269-26-000025.md) | [(7.5)](/filings/0000733269-25-000042.md) | [1.7](/filings/0000733269-25-000057.md) | [11.2](/filings/0000733269-26-000012.md) | [(6.3) d](/filings/0000733269-26-000025.md) | [7.7](/filings/0000733269-26-000047.md) | [27.4](/filings/0000733269-25-000057.md) | [39.9](/filings/0000733269-26-000012.md) | [70.9 d](/filings/0000733269-26-000025.md) | [17.5](/filings/0000733269-26-000047.md) |
| Diluted EPS | $ per share | [0.07](/filings/0000733269-24-000039.md) | [0.21](/filings/0000733269-25-000015.md) | not reported | [(0.11)](/filings/0000733269-25-000042.md) | [0.03](/filings/0000733269-25-000057.md) | [0.17](/filings/0000733269-26-000012.md) | not reported | [0.12](/filings/0000733269-26-000047.md) | [0.42](/filings/0000733269-25-000057.md) | [0.62](/filings/0000733269-26-000012.md) | not reported | [0.28](/filings/0000733269-26-000047.md) |
| Basic EPS | $ per share | [0.07](/filings/0000733269-24-000039.md) | [0.21](/filings/0000733269-25-000015.md) | not reported | [(0.11)](/filings/0000733269-25-000042.md) | [0.03](/filings/0000733269-25-000057.md) | [0.17](/filings/0000733269-26-000012.md) | not reported | [0.12](/filings/0000733269-26-000047.md) | [0.42](/filings/0000733269-25-000057.md) | [0.63](/filings/0000733269-26-000012.md) | not reported | [0.29](/filings/0000733269-26-000047.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [492](/filings/0000733269-23-000039.md) | [499](/filings/0000733269-24-000007.md) | [337](/filings/0000733269-25-000030.md) | [310](/filings/0000733269-24-000027.md) | [339](/filings/0000733269-24-000039.md) | [377](/filings/0000733269-25-000015.md) | [413](/filings/0000733269-26-000025.md) | [364](/filings/0000733269-25-000042.md) | [369](/filings/0000733269-25-000057.md) | [396](/filings/0000733269-26-000012.md) | [380](/filings/0000733269-26-000047.md) | [364](/filings/0000733269-26-000047.md) |
| Current assets | $m | [728](/filings/0000733269-23-000039.md) | [770](/filings/0000733269-24-000007.md) | [602](/filings/0000733269-25-000030.md) | [585](/filings/0000733269-24-000027.md) | [582](/filings/0000733269-24-000039.md) | [644](/filings/0000733269-25-000015.md) | [656](/filings/0000733269-26-000025.md) | [632](/filings/0000733269-25-000042.md) | [647](/filings/0000733269-25-000057.md) | [679](/filings/0000733269-26-000012.md) | [653](/filings/0000733269-26-000047.md) | [636](/filings/0000733269-26-000047.md) |
| Total assets | $m | [1,181](/filings/0000733269-23-000039.md) | [1,225](/filings/0000733269-24-000007.md) | [1,231](/filings/0000733269-25-000030.md) | [1,206](/filings/0000733269-24-000027.md) | [1,195](/filings/0000733269-24-000039.md) | [1,253](/filings/0000733269-25-000015.md) | [1,259](/filings/0000733269-26-000025.md) | [1,232](/filings/0000733269-25-000042.md) | [1,240](/filings/0000733269-25-000057.md) | [1,269](/filings/0000733269-26-000012.md) | [1,294](/filings/0000733269-26-000047.md) | [1,279](/filings/0000733269-26-000047.md) |
| Current liabilities | $m | [187](/filings/0000733269-23-000039.md) | [209](/filings/0000733269-24-000007.md) | [217](/filings/0000733269-25-000030.md) | [190](/filings/0000733269-24-000027.md) | [199](/filings/0000733269-24-000039.md) | [232](/filings/0000733269-25-000015.md) | [248](/filings/0000733269-26-000025.md) | [222](/filings/0000733269-25-000042.md) | [237](/filings/0000733269-25-000057.md) | [250](/filings/0000733269-26-000012.md) | [265](/filings/0000733269-26-000047.md) | [239](/filings/0000733269-26-000047.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [922](/filings/0000733269-23-000039.md) | [946](/filings/0000733269-24-000007.md) | [949](/filings/0000733269-25-000030.md) | [952](/filings/0000733269-24-000027.md) | [932](/filings/0000733269-24-000039.md) | [958](/filings/0000733269-25-000015.md) | [949](/filings/0000733269-26-000025.md) | [948](/filings/0000733269-25-000042.md) | [944](/filings/0000733269-25-000057.md) | [962](/filings/0000733269-26-000012.md) | [972](/filings/0000733269-26-000047.md) | [977](/filings/0000733269-26-000047.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: not reported
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [35.8 d](/filings/0000733269-24-000039.md) | [16.6 d](/filings/0000733269-25-000015.md) | [27.6 d](/filings/0000733269-26-000025.md) | [(9.3)](/filings/0000733269-25-000042.md) | [55.6 d](/filings/0000733269-25-000057.md) | [45.1 d](/filings/0000733269-26-000012.md) | [62.6 d](/filings/0000733269-26-000025.md) | [(15.8)](/filings/0000733269-26-000047.md) | [57.4 d](/filings/0000733269-25-000057.md) | [67.3 d](/filings/0000733269-26-000012.md) | [58.9 d](/filings/0000733269-26-000025.md) | [17.0](/filings/0000733269-26-000047.md) |
| Capital expenditure | $m | [0.2 d](/filings/0000733269-24-000039.md) | [2.2 d](/filings/0000733269-25-000015.md) | [1.8 d](/filings/0000733269-26-000025.md) | [0.2](/filings/0000733269-25-000042.md) | [0.2 d](/filings/0000733269-25-000057.md) | [0.3 d](/filings/0000733269-26-000012.md) | [0.3 d](/filings/0000733269-26-000025.md) | [0.3](/filings/0000733269-26-000047.md) | [0.6 d](/filings/0000733269-25-000057.md) | [0.2 d](/filings/0000733269-26-000012.md) | [0.3 d](/filings/0000733269-26-000025.md) | [0.7](/filings/0000733269-26-000047.md) |
| Share repurchases | $m | [15.1 d](/filings/0000733269-24-000039.md) | [10.0 d](/filings/0000733269-25-000015.md) | [15.2 d](/filings/0000733269-26-000025.md) | [15.8](/filings/0000733269-25-000042.md) | [49.9 d](/filings/0000733269-25-000057.md) | [10.1 d](/filings/0000733269-26-000012.md) | [25.4 d](/filings/0000733269-26-000025.md) | [29.9](/filings/0000733269-26-000047.md) | [49.9 d](/filings/0000733269-25-000057.md) | [39.2 d](/filings/0000733269-26-000012.md) | [75.6 d](/filings/0000733269-26-000025.md) | [17.6](/filings/0000733269-26-000047.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations, us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [67.1](/filings/0000733269-23-000039.md) | [64.8](/filings/0000733269-24-000007.md) | [66.5](/filings/0000733269-24-000027.md) | [67.9](/filings/0000733269-24-000039.md) | [67.9](/filings/0000733269-25-000015.md) | [66.6](/filings/0000733269-25-000042.md) | [67.3](/filings/0000733269-25-000057.md) | [66.7](/filings/0000733269-26-000012.md) | [66.7](/filings/0000733269-26-000047.md) | [65.8](/filings/0000733269-25-000057.md) | [64.3](/filings/0000733269-26-000012.md) | [61.8](/filings/0000733269-26-000047.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 60,794,982 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0000733269-26-000047.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.